Stockreport

2seventy bio appoints Eli Casdin and Charles Newton to its board of directors [Seeking Alpha]

Lyell Immunopharma, Inc.  (LYEL) 
PDF According to TSVT, Casdin is the chief investment officer and founder of Casdin Capital. Casdin Capital owns ~2.3% of the company's outstanding shares as of March 20t [Read more]